Advanced Enzyme Technologies Ltd Q1 Results FY27: What to Expect

Advanced Enzyme Technologies Ltd Q1 Results FY27: Revenue Rs 182 Cr (+45.3% YoY) | PAT Rs 82 Cr (+10.4% YoY). Uniresearch Q1 results preview.

Updated: 1 Jul 2026 • 12:22 pm

Posted by:

Advanced Enzyme Technologies Ltd Q1 Results FY27: What to Expect

This Advanced Enzyme Technologies Ltd Q1 results preview is based on Screener.in consolidated quarterly financials for the Q1 FY26 base quarter, with the Uniresearch trailing-growth model applied to project the Q1 FY27 estimate. Advanced Enzyme Technologies Ltd reported Revenue of Rs 125 Cr and PAT of Rs 74 Cr in Q1 FY26, forming the base for the Advanced Enzyme Technologies Ltd Q1 Results FY27 forecast of Rs 182 Cr Revenue and Rs 82 Cr PAT. Prepared by Ankit Jaiswal, Senior Research Analyst.

Click Here – Get Free Investment Predictions

Table of Contents

Advanced Enzyme Technologies Ltd Q1 Results FY27: Uniresearch Prediction

Metric	Q1 FY26 Actual	Q1 FY27 Uniresearch Prediction	YoY Change
Revenue (Rs Cr)	125	182	+45.3%
PAT (Rs Cr)	74	82	+10.4%

Source: Q1 FY26 actuals from Screener.in. Q1 FY27 prediction for Advanced Enzyme Technologies Ltd applies Uniresearch trailing growth rates (Revenue +45.3%, PAT +10.4%) to Q1 FY26 verified actuals.

Univest – A SEBI-Registered Investment Advisor

Advanced Enzyme Technologies Ltd Q1 Results FY27 Preview: Expectations, Results Date and Latest News

The Advanced Enzyme Technologies Ltd Q1 results expectations for FY27 point to Revenue of Rs 182 Cr (+45.3% YoY) and PAT of Rs 82 Cr (+10.4% YoY), based on the Advanced Enzyme Technologies Ltd Q1 Results FY27 Uniresearch estimate. These Advanced Enzyme Technologies Ltd Q1 results expectations assume the growth trajectory from Q1 FY26 continues into Q1 FY27, supported by sector tailwinds in pharmaceuticals. Investors can use this Advanced Enzyme Technologies Ltd Q1 results preview as a directional reference ahead of the official result declaration.

The Advanced Enzyme Technologies Ltd Q1 results date is not yet officially announced. Typically, Q1 results dates for NSE-listed companies are disclosed via a board meeting notice on the NSE or BSE filing portal, shortly after Q1 FY27 ends. For the latest news on Advanced Enzyme Technologies Ltd Q1 results FY26-27, track the Univest Screener and NSE filing alerts. Once the Advanced Enzyme Technologies Ltd Q1 results date is confirmed, compare actual Advanced Enzyme Technologies Ltd results against this Advanced Enzyme Technologies Ltd Q1 Results FY27 preview.

Q4 FY26 Performance: Context for the Advanced Enzyme Technologies Ltd Q1 Results FY27 Preview

The Advanced Enzyme Technologies Ltd Q1 Results FY27 preview is anchored on Q4 FY26 consolidated Revenue of Rs 116 Cr and PAT of Rs 22 Cr. These Q4 FY26 actuals, combined with Uniresearch trailing growth estimates, form the basis of the Q1 FY27 Uniresearch projection for Advanced Enzyme Technologies Ltd projection.

The sequential comparison also provides useful context. Q4 FY26 Revenue of Rs 116 Cr reflects year-end cycles that may not repeat equally in Q1 FY27. The more meaningful benchmark is the year-on-year comparison against Q1 FY26 Revenue of Rs 125 Cr, where the Advanced Enzyme Technologies Ltd Q1 results expectations target +45.3% growth.

Uniresearch Estimate Behind the Advanced Enzyme Technologies Ltd Q1 Results FY27 Projection

The Q1 FY27 prediction for Advanced Enzyme Technologies Ltd is derived from Uniresearch trailing analysis, which estimates Q1 FY27 Revenue growth of +45.3% and PAT growth of +10.4% YoY. These trailing rates are applied to Q1 FY26 actuals to arrive at the projection of Rs 182 Cr Revenue and Rs 82 Cr PAT.

The Q1 FY27 estimation methodology for Advanced Enzyme Technologies Ltd applies full-year FY27 trailing growth rates (+45.3% Revenue, +10.4% PAT) uniformly to Q1 FY26 actuals. This approach assumes the quarterly trajectory broadly mirrors the full-year trend. Treat this Q1 results preview as a directional benchmark, not a guaranteed outcome.

Advanced Enzyme Technologies Ltd Q1 Results FY27 Expectations: Key Watchpoints

Revenue vs the Uniresearch Estimate

Whether Advanced Enzyme Technologies Ltd results deliver Revenue in line with the Rs 182 Cr Q1 FY27 Uniresearch estimate for Advanced Enzyme Technologies Ltd (+45.3% YoY). Q4 FY26 Revenue was Rs 116 Cr.

PAT Margin Sustainability

PAT of Rs 82 Cr (+10.4% YoY) is the Q1 FY27 Uniresearch estimate for Advanced Enzyme Technologies Ltd. Q4 FY26 PAT was Rs 22 Cr. Margin stability in Advanced Enzyme Technologies Ltd results signals operating leverage.

Management Commentary and Full-Year FY27 Guidance

Beyond the headline Advanced Enzyme Technologies Ltd Q1 results, management commentary will be watched for full-year FY27 guidance on revenue trajectory, margin direction, and capital allocation.

Risks to the Advanced Enzyme Technologies Ltd Q1 Results FY27 Prediction

Below-Estimate Revenue Growth

If actual Advanced Enzyme Technologies Ltd Q1 results Revenue underperforms the +45.3% growth target, the Rs 182 Cr Advanced Enzyme Technologies Ltd Q1 Results FY27 prediction would be revised downward.

PAT Pressure from Costs or Provisions

One-time charges, elevated provisions, or margin headwinds could push Advanced Enzyme Technologies Ltd results PAT below Rs 82 Cr in Q1 FY27.

External and Macro Environment

Macro risks including commodity price movements, rupee volatility, interest rate changes, and FII/DII sentiment shifts could create downside risk in Advanced Enzyme Technologies Ltd results even if company-specific execution remains on track.

Advanced Enzyme Technologies Ltd Q1 Results FY26-27: Sector Growth Drivers and Latest News

The latest news on Advanced Enzyme Technologies Ltd Q1 results FY26-27 from a sector perspective shows that pharmaceuticals is navigating the following growth drivers heading into Q1 FY27. Investors tracking Advanced Enzyme Technologies Ltd Q1 results should monitor these sector-level trends.

Domestic Formulation Growth

India’s domestic pharma market grows at 8-10% annually, led by chronic therapies.

Regulated Market Export Pipeline

USFDA-approved facilities and a growing ANDA pipeline offer incremental export revenues.

Advanced Enzyme Technologies Ltd Q1 Results FY27: What to Expect

The Q1 FY27 Uniresearch projection of Advanced Enzyme Technologies Ltd Revenue Rs 182 Cr and PAT Rs 82 Cr covers the complete Advanced Enzyme Technologies Ltd Q1 results preview, including expectations, risks, and sector outlook. Track the Advanced Enzyme Technologies Ltd Q1 results date confirmation on the Univest Screener for timely updates.

Once the Advanced Enzyme Technologies Ltd results are declared, compare them against this Uniresearch preview to assess beat, meet, or miss. Access expert research and screener tools on Univest to stay updated.

Download the Univest iOS App or Univest Android App for live Advanced Enzyme Technologies Ltd Q1 FY27 result alerts.

Disclaimer: Revenue and PAT actuals sourced from Screener.in consolidated quarterly financial data. Q1 FY27 projections are derived from Uniresearch trailing growth rates applied to Q1 FY26 actuals. These are Uniresearch trailing estimates, not guaranteed outcomes. Investments are subject to market risk. For educational purposes only. SEBI RA INH000013776.

Frequently Asked Questions on Advanced Enzyme Technologies Ltd Q1 Results FY27

What is the Uniresearch prediction for Advanced Enzyme Technologies Ltd Q1 Results FY27?

Ans. Uniresearch projects Q1 FY27 Revenue for Advanced Enzyme Technologies Ltd at Rs 182 Cr (+45.3% YoY) and PAT at Rs 82 Cr (+10.4% YoY), based on trailing analysis of Q1 FY26 actuals (Revenue Rs 125 Cr, PAT Rs 74 Cr). This estimate is directional, not a guaranteed outcome.

What are the Advanced Enzyme Technologies Ltd Q1 Results FY27 expectations?

Ans. The Advanced Enzyme Technologies Ltd Q1 Results FY27 expectations are Revenue Rs 182 Cr (+45.3% YoY) and PAT Rs 82 Cr (+10.4% YoY), per the Uniresearch trailing-growth estimate. These expectations are based on Q1 FY26 actuals from Screener.in.

What were the Q4 FY26 actuals behind the Advanced Enzyme Technologies Ltd Q1 Results FY27 projection?

Ans. Q4 FY26 consolidated Revenue was Rs 116 Cr and PAT was Rs 22 Cr, serving as the most recent sequential reference for this Advanced Enzyme Technologies Ltd Q1 Results FY27 preview.

How reliable is the Advanced Enzyme Technologies Ltd Q1 Results FY27 Uniresearch prediction?

Ans. The Advanced Enzyme Technologies Ltd Q1 Results FY27 preview is a Uniresearch trailing projection, not a guaranteed outcome. Actual results may differ due to macro conditions, seasonal variation, and company-specific execution. Use the projection as a directional benchmark.

What base data is used for the Advanced Enzyme Technologies Ltd Q1 Results FY27 Uniresearch projection?

Ans. The Advanced Enzyme Technologies Ltd Q1 Results FY27 projection uses Q1 FY26 consolidated actuals (Revenue Rs 125 Cr, PAT Rs 74 Cr) from Screener.in, with trailing growth rates (+45.3% Revenue, +10.4% PAT) applied to derive the estimate.

What are the key risks to the Advanced Enzyme Technologies Ltd Q1 Results FY27 estimate?

Ans. Key risks to the Advanced Enzyme Technologies Ltd Q1 Results FY27 include usfda regulatory risk, us generic pricing erosion, and broader macro headwinds that could cause actual Advanced Enzyme Technologies Ltd results to undershoot the Uniresearch Q1 results preview.

When will Advanced Enzyme Technologies Ltd Q1 Results FY27 results be announced?

Ans. The Advanced Enzyme Technologies Ltd Q1 results date has not been officially announced yet. Q1 FY27 results for NSE-listed companies are typically declared shortly after Q1 FY27 ends, with the Advanced Enzyme Technologies Ltd Q1 results date disclosed via a board meeting notice on the NSE or BSE filing portal. Track the latest news on Advanced Enzyme Technologies Ltd Q1 results FY26-27 on the Univest Screener for timely updates.